Welcome to Hologic Investor Relations

 Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products. The Company’s core business units focus on diagnostics, breast health, GYN surgical, and skeletal health. With a unified suite of technologies and a robust research and development program, Hologic is dedicated to The Science of Sure.

The Company's Common Stock is listed on the Nasdaq Global Select Market under the trading symbol "HOLX".

Recent News
Apr 16, 2015

Hologic, Inc. (NASDAQ: HOLX) today commented on an important cervical cancer screening studyi published on-line this week in Cancer Cytopathology, a peer-reviewed journal of the American Cancer...

Apr 6, 2015

Hologic, Inc. (NASDAQ: HOLX) announced today that the Company plans to release its operating results for the second quarter of fiscal 2015 on Wednesday, April 29, 2015, after the market closes. In...

Apr 1, 2015

Hologic, Inc. (NASDAQ: HOLX) announced today that it has notified holders of the 2.00% Convertible Exchange Senior Notes due 2037 (CUSIP No. 436440 AB7) issued November 23, 2010, and Wilmington...

Feb 4, 2015

Hologic, Inc. (NASDAQ: HOLX) announced today that the Company will present at these upcoming investor conferences: The 2015 Leerink Global Healthcare Conference in New York on Wednesday, February...

More ›